CA2676620A1 — Methods for preventing and treating neurodegenerative disorders
Assigned to Boehringer Ingelheim International GmbH · Expires 2008-07-31 · 18y expired
What this patent protects
The present invention relates to a method for treating, preventingor slowing, delaying or reversing progression of one or more neurodegenerative disorders in a patient in need thereof characterized by administering a glucopyranosyl-substituted benzene derivative, atautomer, stere…
USPTO Abstract
The present invention relates to a method for treating, preventingor slowing, delaying or reversing progression of one or more neurodegenerative disorders in a patient in need thereof characterized by administering a glucopyranosyl-substituted benzene derivative, atautomer, stereoisomer, mixtureorsalt thereof,as defined in claim 1 to the patient in need thereof.
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.